The DNA Translocase Activity of FANCM Protects Stalled Replication Forks
Overview
Molecular Biology
Authors
Affiliations
FANCM is the most highly conserved protein within the Fanconi anaemia (FA) tumour suppressor pathway. However, although FANCM contains a helicase domain with translocase activity, this is not required for its role in activating the FA pathway. Instead, we show here that FANCM translocaseactivity is essential for promoting replication fork stability. We demonstrate that cells expressing translocase-defective FANCM show altered global replication dynamics due to increased accumulation of stalled forks that subsequently degenerate into DNA double-strand breaks, leading to ATM activation, CTBP-interacting protein (CTIP)-dependent end resection and homologous recombination repair. Accordingly, abrogation of ATM or CTIP function in FANCM-deficient cells results in decreased cell survival. We also found that FANCM translocase activity protects cells from accumulating 53BP1-OPT domains, which mark lesions resulting from problems arising during replication. Taken together, these data show that FANCM plays an essential role in maintaining chromosomal integrity by promoting the recovery of stalled replication forks and hence preventing tumourigenesis.
Mechanism of structure-specific DNA binding by the FANCM branchpoint translocase.
Abbouche L, Murphy V, Gao J, van Twest S, Sobinoff A, Auweiler K Nucleic Acids Res. 2024; 52(18):11029-11044.
PMID: 39189453 PMC: 11472164. DOI: 10.1093/nar/gkae727.
FANCM Gene Variants in a Male Diagnosed with Sertoli Cell-Only Syndrome and Diffuse Astrocytoma.
Klaric M, Maric T, Zunic L, Trgovec-Greif L, Rokic F, Fiolic A Genes (Basel). 2024; 15(6).
PMID: 38927643 PMC: 11202954. DOI: 10.3390/genes15060707.
Crucial role of the NSE1 RING domain in Smc5/6 stability and FANCM-independent fork progression.
Lorite N, Apostolova S, Guasch-Valles M, Pryer A, Unzueta F, Freire R Cell Mol Life Sci. 2024; 81(1):251.
PMID: 38847937 PMC: 11335289. DOI: 10.1007/s00018-024-05275-3.
The Molecular Mechanisms and Therapeutic Prospects of Alternative Lengthening of Telomeres (ALT).
Sohn E, Goralsky J, Shay J, Min J Cancers (Basel). 2023; 15(7).
PMID: 37046606 PMC: 10093677. DOI: 10.3390/cancers15071945.
Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT).
Kusuma F, Prabhu A, Tieo G, Ahmed S, Dakle P, Yong W Nat Commun. 2023; 14(1):1919.
PMID: 37024489 PMC: 10079688. DOI: 10.1038/s41467-023-37633-3.